02/21/2025
6:28 PM | Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:51 PM | Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
7:21 PM | Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
10:23 AM | Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
4:11 PM | Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
1:20 PM | Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
5:13 AM | Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
3:00 PM | Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SCHEDULE 13G/A | |
11/19/2024
5:45 PM | Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:30 PM | Adaptive Biotechnologies (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
11/13/2024
8:00 AM | Adaptive Biotechnologies (Subject)
Matrix Capital Management Company, LP (Filed by)
| Form SC 13G/A | |
Get the Latest News and Ratings for ADPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Adaptive Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. |
11/12/2024
12:30 PM | Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
2:15 PM | Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
| Form SC 13G | |
11/07/2024
3:30 PM | Adaptive Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
5:07 AM | Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
| Form SC 13G | |
11/04/2024
9:58 AM | Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/11/2024
3:14 PM | Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G/A | |
10/10/2024
4:47 PM | Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:27 PM | Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:18 PM | Adaptive Biotechnologies (Subject)
Taylor Stacy L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:30 PM | Adaptive Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:15 PM | Adaptive Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:22 PM | Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G | |
05/24/2024
11:01 AM | Adaptive Biotechnologies (Filer)
| Form DEFA14A | |
05/17/2024
5:35 PM | Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
4:29 PM | Adaptive Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:30 PM | Adaptive Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:55 PM | Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:45 PM | Adaptive Biotechnologies (Issuer)
OWEN KATEY EINTERZ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:46 PM | Adaptive Biotechnologies (Issuer)
Pellini Michael J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:38 PM | Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/06/2024
6:39 PM | Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:40 PM | Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:40 PM | Adaptive Biotechnologies (Issuer)
PETERSON TYCHO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:41 PM | Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:41 PM | Adaptive Biotechnologies (Issuer)
RUBINSTEIN JULIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:42 PM | Adaptive Biotechnologies (Issuer)
BENZENO SHARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:42 PM | Adaptive Biotechnologies (Issuer)
LO FRANCIS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:42 PM | Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:43 PM | Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:43 PM | Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon “obliterates” Bill Gates? (Ad) All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them Click here for my report |
03/06/2024
6:45 PM | Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:45 PM | Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
